pe2228 vs dihexa Frontiers Dihexa (PNB-0408) | C27H44N4O5 |
Dihexa (PNB 0408) C27H44N4O5 CID 125355097 PubChem PE 22 28 (10mg) Neuropeptides Peptide Hackers Protagonist's exciting 2025 continues with today's announcement: Rusfertide has received Breakthrough Therapy Designation from the U.S. FDA for the treatment of polycythemia vera (PV). This designation complements rusfertide's Orphan Drug and Fast Targeting Metabolic Vulnerabilities Reveals Hexokinase 2 as a Key Mediator of Resistance to Osimertinib in Non Small Cell Lung Cancer Models ACS Pharmacology & Translational Science Structural basis of phosphodiesterase 5 conformational organization revealed by a PDE6 PDE5 chimera ScienceDirect
Pay in 4 interest-free payments of $6.15 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1


